Long-term follow-up of a phase Ⅱ clinical trial on pUDK-hepatocyte growth factor treatment for rest pain and ulcers caused by critical limb ischemia

Cui Shijun, Guo Jianming, Tong Zhu, Guo Lianrui, Gu Yongquan

PDF(423 KB)
PDF(423 KB)
Adverse Drug Reactions Journal ›› 2024, Vol. 26 ›› Issue (4) : 193-197. DOI: 10.3760/cma.j.cn114015-20230918-00686

Long-term follow-up of a phase Ⅱ clinical trial on pUDK-hepatocyte growth factor treatment for rest pain and ulcers caused by critical limb ischemia

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2024, 26(4): 193-197 https://doi.org/10.3760/cma.j.cn114015-20230918-00686

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(423 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉